Nilo Therapeutics

📍 New York City, United States👥 16 employees💰 Last funded Jul 2024
Biotechnology Research🌐 nilotx.com
Website LinkedIn
NILO Therapeutics is an early-stage biotech company developing groundbreaking therapies for autoimmune and inflammatory diseases. Our experienced team brings together diverse interdisciplinary expertise to modulate immune responses via activation of neural circuits. United by our passion for discovering and translating novel biology, we are dedicated to advancing human health through transformative science.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Nilo Therapeutics?
Nilo Therapeutics has 1 investors on record on gritt.io.
When did Nilo Therapeutics last raise funding?
The most recent investment in Nilo Therapeutics recorded on gritt.io was in July 2024.
What industry is Nilo Therapeutics in?
Nilo Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Nilo Therapeutics based?
Nilo Therapeutics is headquartered in New York City, United States.